[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,305
Citations 0
Comment and Response
August 7, 2013

Therapy for Chemotherapy-Induced Peripheral Neuropathy

Author Affiliations
  • 1Cancer Research UK, University of Edinburgh, Edinburgh, Scotland
  • 2Western General Hospital, University of Edinburgh, Edinburgh, Scotland
JAMA. 2013;310(5):537-538. doi:10.1001/jama.2013.7902

To the Editor Dr Smith and colleagues1 concluded that “among patients with painful chemotherapy-induced peripheral neuropathy, the use of duloxetine compared with placebo for 5 weeks resulted in a greater reduction in pain.”

The overall strength of effect underpinning this conclusion, however, is relatively small, despite reaching statistical significance. The authors most clearly demonstrated this in Figure 2 in the article, which shows closely approximated or overlapping confidence intervals in both the initial and crossover treatment periods.

First Page Preview View Large
First page PDF preview
First page PDF preview
×